Y020-9330 Screening compound: 3-[3-(4-chlorophenyl)-2-methyl-6-oxopyrazolo[1,5-a]pyrido[3,4-e]pyrimidin-7(6H)-yl]propanoic acid

Y020-9330 Screening compound: 3-[3-(4-chlorophenyl)-2-methyl-6-oxopyrazolo[1,5-a]pyrido[3,4-e]pyrimidin-7(6H)-yl]propanoic acid
Y020-9330 Screening compound: 3-[3-(4-chlorophenyl)-2-methyl-6-oxopyrazolo[1,5-a]pyrido[3,4-e]pyrimidin-7(6H)-yl]propanoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-9330
3-[3-(4-chlorophenyl)-2-methyl-6-oxopyrazolo[1,5-a]pyrido[3,4-e]pyrimidin-7(6H)-yl]propanoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-9330

Molecular Formula

C19H15ClN4O3 (C19 H15 ClN4 O3)

Compound Name

3-[3-(4-chlorophenyl)-2-methyl-6-oxopyrazolo[1,5-a]pyrido[3,4-e]pyrimidin-7(6H)-yl]propanoic acid

IUPAC name

3-[5-(4-chlorophenyl)-4-methyl-10-oxo-23711-tetraazatricyclo[7.4.0.0^{26}]trideca-1(9)35712-pentaen-11-yl]propanoic acid

SMILES

Cc(c(-c(cc1)ccc1Cl)c1nc2)nn1c(C=CN1CCC(O)=O)c2C1=O

InChI

InChI=1S/C19H15ClN4O3/c1-11-17(12-2-4-13(20)5-3-12)18-21-10-14-15(24(18)22-11)6-8-23(19(14)27)9-7-16(25)26/h2-6,8,10H,7,9H2,1H3,(H,25,26)

InChI Key

HCAUIJSQOHHOGP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15197947

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

382.81

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.452

Distribution Coefficient, logD

-1.080

Water Solubility, LogSw

-2.74

Polar Surface Area

66.639

Acid Dissociation Constant (pKa)

4.87

Base Dissociation Constant (pKb)

-0.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.80

Y020-9330 in Drug Discovery

Included in Screening Libraries

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with Y020-9330 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-9330?
Check Price and Availability of Y020-9330, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-9330 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-9330
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-9330
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-9330 available by request